Robust demand across its pharmaceutical and specialty solutions segment was the impetus behind Cardinal Health raising its fiscal 2025 enterprise guidance, said Jason Hollar, CEO of Cardinal ...
Mizuho Securities analyst Steven Valiquette has reiterated their bullish stance on CAH stock, giving a Buy rating yesterday. Steven Valiquette has given his Buy rating due to a combination of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback